We are live on ! Find out more
CCP

Corbin Capital Partners Portfolio holdings

AUM $61.3M
1-Year Est. Return 53.03%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+53.03%
3 Year Est. Return
+87.66%
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
-$61.6M
Cap. Flow
-$70.5M
Cap. Flow %
-59.48%
Top 10 Hldgs %
78.84%
Holding
89
New
10
Increased
4
Reduced
4
Closed
21

Similar funds

Corbin Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Corbin Capital Partners held 89 positions worth $118M, down 34% from $180M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Corbin Capital Partners withdrew a net $70.5M in Q2 2023, closing 21 positions and reducing 4 holdings. Its most notable exit was Argo Group International Holdings, Ltd., an estimated $39M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 49% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Corbin Capital Partners opened a new position in Indivior Pharmaceuticals worth $3.64M.

  • Corbin Capital Partners's largest Q2 2023 buy was Indivior Pharmaceuticals: 199,574 shares worth $3.64M.
  • Corbin Capital Partners added most to Alpha Tau Medical Warrant in Q2 2023, an estimated $217K increase.
  • Corbin Capital Partners's biggest Q2 2023 reduction was AdTheorent Holding Co, cutting an estimated $1.04M.
  • Corbin Capital Partners fully exited Argo Group International Holdings, Ltd. in Q2 2023, selling an estimated $39M.
  • Corbin Capital Partners's ten largest holdings make up 79% of its $118M portfolio in Q2 2023.
  • Corbin Capital Partners opened 10 new positions and closed 21 in Q2 2023.
  • Corbin Capital Partners's portfolio value fell 34% quarter-over-quarter to $118M.

Based on Corbin Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.